Cellectar Biosciences, Inc. SEC filings CLRB

Cellectar Biosciences, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 7, 2011. Its latest annual report, Form 10-K, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.

Cellectar Biosciences, Inc. SEC filings
Form Description Filed Period
424B3 Prospectus Jun 2, 2026 —
S-1/A Amended registration statement May 29, 2026 —
S-1 Registration statement May 19, 2026 —
424B5 Prospectus supplement May 6, 2026 —
424B3 Prospectus Nov 21, 2025 —
S-1 Registration statement Oct 20, 2025 —
424B4 Prospectus Jul 2, 2025 —
S-1/A Amended registration statement Jun 30, 2025 —
S-1 Registration statement Jun 26, 2025 —
424B3 Prospectus Feb 7, 2025 —
S-1 Registration statement Jan 29, 2025 —
S-3 Shelf registration May 24, 2024 —
424B3 Prospectus Oct 31, 2023 —
S-3/A Form s-3/a Oct 25, 2023 —
S-3 Shelf registration Oct 5, 2023 —
424B3 Prospectus Dec 5, 2022 —
S-1 Registration statement Nov 23, 2022 —
424B5 Prospectus supplement Oct 24, 2022 —
424B5 Prospectus supplement Oct 20, 2022 —
S-8 Employee stock plan registration Aug 5, 2022 —
424B3 Prospectus Feb 1, 2021 —
S-3 Shelf registration Jan 21, 2021 —
424B5 Prospectus supplement Dec 23, 2020 —
424B5 Prospectus supplement Dec 23, 2020 —
S-3 Shelf registration Aug 11, 2020 —
424B4 Prospectus Jun 4, 2020 —
S-1MEF Filing Jun 2, 2020 —
FWP Free writing prospectus May 20, 2020 —
S-1/A Amended registration statement May 20, 2020 —
S-1 Registration statement May 8, 2020 —
S-8 Employee stock plan registration Aug 26, 2019 —
S-1 Registration statement May 31, 2019 —
424B5 Prospectus supplement May 17, 2019 —
424B4 Prospectus Jul 27, 2018 —
S-1MEF Filing Jul 26, 2018 —
FWP Free writing prospectus Jul 18, 2018 —
S-1/A Amended registration statement Jul 18, 2018 —
S-1 Registration statement Jun 15, 2018 —
S-8 Employee stock plan registration Nov 9, 2017 —
S-1 Registration statement Nov 9, 2017 —
424B5 Prospectus supplement Oct 11, 2017 —
S-3/A Filing Sep 15, 2017 —
S-3 Shelf registration Jun 5, 2017 —
424B4 Prospectus Nov 23, 2016 —
S-1/A Amended registration statement Nov 18, 2016 —
FWP Free writing prospectus Nov 14, 2016 —
S-1/A Amended registration statement Nov 14, 2016 —
S-1/A Amended registration statement Nov 9, 2016 —
S-1 Registration statement Oct 28, 2016 —
S-1 Registration statement Oct 21, 2016 —
POS AM Filing Jul 26, 2016 —
POS AM Filing Jul 1, 2016 —
S-3 Shelf registration Jun 17, 2016 —
424B5 Prospectus supplement May 24, 2016 —
424B4 Prospectus Apr 18, 2016 —
S-1/A Amended registration statement Apr 14, 2016 —
FWP Free writing prospectus Mar 25, 2016 —
S-1/A Amended registration statement Mar 21, 2016 —
S-1 Registration statement Dec 18, 2015 —
S-3 Shelf registration Nov 24, 2015 —
424B5 Prospectus supplement Sep 30, 2015 —
S-3/A Form s-3/a Sep 2, 2015 —
S-3 Shelf registration Jan 9, 2015 —
424B3 Prospectus Nov 12, 2014 —
424B4 Prospectus Aug 18, 2014 —
S-1/A Amended registration statement Aug 6, 2014 —
FWP Free writing prospectus Aug 4, 2014 —
S-1/A Amended registration statement Jul 7, 2014 —
S-1 Registration statement May 19, 2014 —
S-8 Employee stock plan registration Apr 14, 2014 —
424B3 Prospectus Feb 14, 2014 —
424B3 Prospectus Feb 14, 2014 —
424B3 Prospectus Feb 11, 2014 —
424B3 Prospectus Feb 11, 2014 —
424B3 Prospectus Dec 26, 2013 —
424B3 Prospectus Dec 26, 2013 —
424B3 Prospectus Nov 15, 2013 —
424B3 Prospectus Nov 15, 2013 —
424B3 Prospectus Oct 15, 2013 —
424B3 Prospectus Oct 15, 2013 —
424B3 Prospectus Aug 15, 2013 —
424B3 Prospectus Aug 15, 2013 —
424B3 Prospectus Aug 2, 2013 —
424B3 Prospectus Aug 2, 2013 —
424B3 Prospectus May 16, 2013 —
424B3 Prospectus May 16, 2013 —
424B3 Prospectus May 10, 2013 —
424B3 Prospectus May 10, 2013 —
POS AM Filing Apr 30, 2013 —
POS AM Filing Apr 30, 2013 —
424B1 Prospectus - rule 424(b)(1) Feb 15, 2013 —
424B3 Prospectus Feb 15, 2013 —
424B3 Prospectus Feb 15, 2013 —
S-1/A Amended registration statement Jan 31, 2013 —
424B3 Prospectus Dec 19, 2012 —
424B3 Prospectus Dec 19, 2012 —
S-1 Registration statement Nov 20, 2012 —
424B3 Prospectus Nov 7, 2012 —
424B3 Prospectus Nov 7, 2012 —
424B3 Prospectus Oct 29, 2012 —
424B3 Prospectus Oct 29, 2012 —
424B3 Prospectus Oct 17, 2012 —
424B3 Prospectus Oct 17, 2012 —
424B3 Prospectus Sep 12, 2012 —
424B3 Prospectus Sep 12, 2012 —
424B3 Prospectus Aug 10, 2012 —
424B3 Prospectus Aug 10, 2012 —
424B3 Prospectus Jul 27, 2012 —
S-1 Registration statement Jul 17, 2012 —
424B1 Rule 424(b)(1) Jun 8, 2012 —
S-1/A Amended registration statement Jun 6, 2012 —
S-1/A Amended registration statement May 14, 2012 —
S-1 Registration statement Apr 9, 2012 —
424B3 Prospectus Dec 21, 2011 —
424B3 Prospectus Dec 8, 2011 —
424B1 Form 424b1 Dec 2, 2011 —
S-1/A Amended registration statement Nov 23, 2011 —
S-1/A Amended registration statement Nov 9, 2011 —

Showing 118 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CLRB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Florham Park, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1279704
Former names
NOVELOS THERAPEUTICS, INC. (until Feb 11, 2014); COMMON HORIZONS INC (until Jun 2, 2005)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.